Gene impedes recovery from alcoholism

People who are alcohol-dependent and who also carry a particular variant of a gene run an increased risk of premature death. This is a recent finding from the interdisciplinary research at the Department of Psychology and the Sahlgrenska Academy at the University of Gothenburg, Sweden.

Researchers in the longitudinal project Goteborg Alcohol Research Project (GARP) have been investigating the dopamine D2 receptor gene and found that a variant of this gene is overrepresented in people with severe , and that it is linked to a number of different that can be of vital significance to the person affected.

"Our research shows that alcohol-dependent individuals, who are also carriers of this , run 10 times the risk of dying prematurely, compared with the average population," says Claudia Fahlke, a representative from the research team.

In a study published recently in the journal Alcohol and Alcoholism (issue 46), the research team shows that this gene variant also appears to be associated with a higher tendency among these individuals to suffer a relapse, even if they have undergone treatment for their alcohol dependency. This may provide one explanation as to the higher mortality rate in people suffering from alcohol dependency, who are carriers of this gene variant.

"This knowledge emphasises the importance of developing methods for early identifying individuals who are also carriers of this gene variant, since the consequences can be so serious," says Jan Balldin at the Sahlgrenska Academy, University of Gothenburg.

Citation: Gene impedes recovery from alcoholism (2011, November 15) retrieved 28 March 2024 from https://medicalxpress.com/news/2011-11-gene-impedes-recovery-alcoholism.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New evidence on why alcohol consumption is a risk factor for cancer

 shares

Feedback to editors